945376-95-4

Basic information

• Product Name: P-1004 (in stock)
• Synonyms: P-1004 (in stock);4-(3-Bromopyrazolo[1,5-a]pyrimidin-6-yl)phenol;P-1004;4-(3-Bromopyrazolo[1,5-a]pyrimidin-6-yl)
• CAS NO: 945376-95-4
• Molecular Formula: C₁₂H₈BrN₃O
• Molecular Weight: 290.11542
• Mol File: 945376-95-4.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Density: 1.70
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: P-1004 (in stock)(CAS DataBase Reference)
• NIST Chemistry Reference: P-1004 (in stock)(945376-95-4)
• EPA Substance Registry System: P-1004 (in stock)(945376-95-4)

Safety Data

• Hazardous Substances Data: 945376-95-4(Hazardous Substances Data)

Usage

General Description

P-1004 is a chemical available in stock that is a white solid with a molecular weight of 318.27 g/mol. It is also known by its chemical name 2-Methylbenzamide and is commonly used in the pharmaceutical and chemical industries. P-1004 is a key building block in the synthesis of various organic compounds and is known for its high purity and quality. It is often used as an intermediate in the production of pharmaceuticals, dyes, and other specialty chemicals. Additionally, P-1004 is known for its stability and compatibility with a wide range of solvents, making it a versatile and valuable chemical for various industrial applications.

Upstream product

• 16461-94-2 3-amino-4-bromo-1H-pyrazole 
• 81267-58-5 3-Dimethylamino-2-(4-hydroxyphenyl)acroleine 

Downstream Products

• 216661-58-4 3-(pyridin-4-yl)-6-(4-methoxyphenyl)-pyrazolo(1,5-A)pyrimidine 
• 515880-87-2 6-(4-hydroxyphenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine 
• 1450754-58-1 6-(4-(2-(3-(but-3-ynyl)-3H-diazirin-3-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine 
• 216661-83-5 3-(bromo)-6-(4-methoxyphenyl)-pyrazolo(1,5-A)pyrimidine 
• 1258311-28-2 C₁₈H₁₉BrN₄O₂ 
• 945376-96-5 3-bromo-6-[4-(2-piperidin-1-ylethoxy)phenyl]pyrazolo[1,5-a]pyrimidine 

Relevant articles and documents

BMP INHIBITORS AND METHODS OF USE THEREOF

The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds may also be used to reduce circulating levels of ApoB-100 or LDL and treat or prevent acquired or congenital hypercholesterolemia or hyperlipoproteinemia; diseases, disorders, or syndromes associated with defects in lipid absorption or metabolism; or diseases, disorders, or syndromes caused by hyperlipidemia.